| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030032457 |
| P356 | DOI | 10.1007/BF02431539 |
| P3181 | OpenCitations bibliographic resource ID | 2973384 |
| P698 | PubMed publication ID | 2906446 |
| P2093 | author name string | G Curzon | |
| G A Kennett | |||
| P2860 | cites work | Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors | Q24681893 |
| Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats | Q28249545 | ||
| Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist | Q28282022 | ||
| Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors | Q34163531 | ||
| [3H]Mesulergine, a selective ligand for serotonin-2 receptors | Q34271841 | ||
| Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). | Q34562275 | ||
| The effect of cyproheptadine on food consumption in the fasted rat | Q35226386 | ||
| Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding | Q39099247 | ||
| An in vivo model for investigating alpha 1- and alpha 2-receptors in the CNS: studies with mianserin | Q39303809 | ||
| Neurobiology of an anorectic drug: fenfluramine | Q39739956 | ||
| Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity | Q40468890 | ||
| Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin | Q42203475 | ||
| The effect of cyproheptadine on water and food intake and on body weight in the fasted adult and weanling rats | Q43002386 | ||
| Fluoxetine-induced weight loss in overweight, nondepressed subjects. | Q43534743 | ||
| 1-(1-Naphthyl)piperazine, a central serotonin agonist | Q45259605 | ||
| Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors | Q46927707 | ||
| Effect of cyproheptadine on asthmatic children. Study of appetite, weight gain, and linear growth | Q47427119 | ||
| Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia | Q48151868 | ||
| Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding | Q48170120 | ||
| Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors | Q48289171 | ||
| 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance | Q48419394 | ||
| Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites | Q48419772 | ||
| Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety | Q48437735 | ||
| Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs | Q48470318 | ||
| 5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity | Q48499755 | ||
| Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex | Q48594638 | ||
| The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants | Q48663812 | ||
| Amino acid imbalance, protein intake, and changes in rat brain and plasma amino acids | Q48795315 | ||
| Effect of thiazol-4-ylmethoxyamine, a new inhibition of histamine biosynthesis on brain histamine, monoamine levels and behavior. | Q51120489 | ||
| Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. | Q53950653 | ||
| 5-HT1B agonists induce anorexia at a postsynaptic site | Q60054778 | ||
| Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes | Q70026203 | ||
| Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat | Q70151999 | ||
| Unusual appetites in patients on mianserin | Q72420631 | ||
| APPETITE STIMULATING PROPERTIES OF CYPROHEPTADINE | Q76852165 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 93-100 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors | |
| P478 | volume | 96 |
| Q45236952 | 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221. |
| Q37295090 | 5-HT receptors: subtypes and second messengers |
| Q35942139 | 5-HT1 receptors and behavior |
| Q34243207 | 5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model |
| Q52243568 | 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats. |
| Q28282073 | 5-HT2 receptor antagonists and migraine therapy |
| Q34766538 | 5-HT2C ligands: recent progress |
| Q33936081 | 5-HT2C receptor modulation and the treatment of obesity. |
| Q52204350 | 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine. |
| Q38449992 | 5-hydroxytryptamine medications for the treatment of obesity |
| Q52272042 | A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393. |
| Q39164871 | A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment |
| Q47892388 | Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. |
| Q43153429 | Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure |
| Q28235776 | Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats |
| Q60054753 | An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats |
| Q24674037 | Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens |
| Q51171045 | Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. |
| Q34425588 | BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats |
| Q35942144 | Behavioral pharmacology of antagonists at 5-HT2/5-HT1C receptors |
| Q52531846 | Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. |
| Q44026253 | Central administration of mCPP, a serotonin 5-HT(2B/2C) agonist, decreases water intake in rats. |
| Q35942133 | Centrally active 5-HT receptor agonists and antagonists |
| Q41835936 | Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. |
| Q77409201 | Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats |
| Q42454932 | Concurrent measurement of serotonin metabolism and single neuron activity changes in the lateral hypothalamus of freely behaving rat |
| Q68304997 | Corticosterone and prolactin response to TFMPP in rats during repeated antidepressant administration |
| Q34638548 | Crystal structure of 1-(3-chloro-phen-yl)piperazin-1-ium picrate-picric acid (2/1). |
| Q38308141 | Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. |
| Q48336234 | Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity |
| Q71671084 | Decreases of plasma tryptophan concentrations following restricted feeding do not decrease serotonin and its metabolite in rat brain |
| Q43019778 | Determining the subjective effects of TFMPP in human males. |
| Q52052476 | Differential effect of lithium treatment on fenfluramine-induced decreases in food intake and locomotor activity in rats. |
| Q42573999 | Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia |
| Q38004444 | Distribution of serotonin receptors. |
| Q41026217 | Dopamine receptor subtype agonists and feeding behavior |
| Q34426212 | Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids |
| Q51088144 | Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes. |
| Q33540480 | Effects of centrally administered anxiolytic compounds in animal models of anxiety |
| Q35686715 | Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory |
| Q73235831 | Effects of fluvoxamine on food intake during rebound hyperphagia in rats |
| Q48348417 | Effects of food deprivation and mCPP treatment on the microstructure of ingestive behaviour of male and female rats |
| Q51146727 | Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP. |
| Q72176163 | Effects of indorenate on food intake: a comparison with fenfluramine and amphetamine |
| Q51171870 | Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. |
| Q48402868 | Effects of mesulergine treatment on diet selection, brain serotonin (5-HT) and dopamine (DA) turnover in free feeding rats |
| Q33899072 | Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action |
| Q73314507 | Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats |
| Q46230494 | Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. |
| Q71539062 | Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats |
| Q35577348 | Estradiol increases the anorexia associated with increased 5-HT(2C) receptor activation in ovariectomized rats. |
| Q68695538 | Evidence for 5-HT2 receptor mediation in quipazine anorexia |
| Q52046642 | Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) |
| Q41592493 | Evidence for the Association of a Deleted Variant in the 5'-Flanking Region of the Chicken serotonin transporter (5-HTT) Gene with a Temporary Increase in Feed Intake and Growth Rate |
| Q40691612 | Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors |
| Q34317911 | Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety |
| Q34086043 | Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors |
| Q44247466 | Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor |
| Q47277856 | Hypothalamic serotonin in control of eating behavior, meal size, and body weight |
| Q89127977 | Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis |
| Q34322537 | In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist |
| Q40457646 | Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans? |
| Q67515297 | Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats |
| Q68792458 | Involvement of 5-HT1C-receptors in drug-induced penile erections in rats |
| Q44784221 | Local perfusion of mCPP into ventromedial hypothalamic nucleus, but not into lateral hypothalamic area and frontal cortex, inhibits food intake in rats |
| Q46253898 | Long-term consumption of sugar-rich diet decreases the effectiveness of somatodendritic serotonin-1A receptors |
| Q36540929 | Mechanisms of Serotonergic Affect Control |
| Q43709865 | Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists |
| Q41026153 | Multiple serotonin receptors: opportunities for new treatments for obesity? |
| Q43816354 | On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination |
| Q44400212 | Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. |
| Q42637221 | Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity. |
| Q48767110 | Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats |
| Q26775537 | Peripheral Serotonin: a New Player in Systemic Energy Homeostasis |
| Q34342536 | Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors |
| Q34407191 | Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans. |
| Q36709588 | Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications |
| Q24658013 | Pharmacological targeting of the serotonergic system for the treatment of obesity |
| Q68913203 | Plasma and CSF tryptophan in cancer anorexia |
| Q41165308 | Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia |
| Q71378289 | RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors |
| Q48420814 | Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine |
| Q42563833 | Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. |
| Q48880053 | Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. |
| Q34127528 | Role of 5-hT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat. |
| Q48238780 | Role of serotonin-1A receptors in restraint-induced behavioral deficits and adaptation to repeated restraint stress in rats |
| Q34432766 | SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist |
| Q28341362 | Selective reduction by serotonergic agents of hypertonic saline consumption in rats: evidence for possible 5-HT1C receptor mediation |
| Q37956399 | Serotonergic anti-obesity agents: past experience and future prospects |
| Q28282364 | Serotonergic drugs : effects on appetite expression and use for the treatment of obesity |
| Q72579640 | Serotonergic influences on male sexual behavior of rhesus monkeys: effects of serotonin agonists |
| Q51395356 | Serotonergic neurons projecting to hippocampus activate locomotion. |
| Q46937759 | Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse. |
| Q43913101 | Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. |
| Q36509808 | Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors |
| Q38004466 | Serotonin and appetite |
| Q36718579 | Serotonin and the regulation of mammalian energy balance |
| Q26749092 | Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity |
| Q38004475 | Serotonin in human eating disorders |
| Q37914869 | Serotonin receptors: clinical implications |
| Q36628828 | Sucrose intake and fasting glucose levels in 5-HT(1A) and 5-HT(1B) receptor mutant mice |
| Q38004418 | The 5-HT1B receptors |
| Q34551208 | The anorexigenic effect of serotonin is mediated by the generation of NADPH oxidase-dependent ROS |
| Q48951857 | The antiemetic drug trimethobenzamide prevents hypophagia due to acetyl salicylate, but not to 5-HT1B or 5-HT1C agonists |
| Q44797812 | The effects of 5-HT on feeding behaviour in mianserin- or cyproheptadine-pretreated rats. |
| Q44779786 | The effects of 5-HT receptor ligands on ultrasonic calling in mouse pups |
| Q28143982 | The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds |
| Q24642641 | The neurobiology and genetics of impulse control disorders: relationships to drug addictions |
| Q36589680 | The nucleus accumbens 5-HTR₄-CART pathway ties anorexia to hyperactivity |
| Q34221291 | The role of serotonin in eating disorders |
| Q45162725 | Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats |
| Q37878154 | Towards a serotonin-dependent leptin roadmap in the brain |
| Q34000520 | Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. |
| Q35823591 | We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders. |
| Q28307494 | m-Chlorophenylpiperazine decreases food intake in a test meal |
Search more.